EQ NASDAQ
Equillium, Inc.
1W: -1.4%
1M: -19.1%
3M: -40.4%
YTD: -11.1%
1Y: -3.5%
3Y: +130.5%
5Y: -76.2%
$1.36
+0.11 (+8.80%)
Weekly Expected Move ±13.3%
$1
$1
$1
$1
$2
Credit Risk of going bust: higher than 56% of companies Debt: 0.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99.8%), Equillium, Inc. would be worth roughly what it owes.
Total debt $584K against a stock market value of $86.2M.
Distance to default 4.53 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $498K (short-term plus half of long-term), stock volatility 103.7%; Altman Z'' 13.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down 99.8%), Equillium, Inc. would be worth roughly what it owes.
Total debt $584K against a stock market value of $86.2M.
Distance to default 4.53 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $498K (short-term plus half of long-term), stock volatility 103.7%; Altman Z'' 13.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-09-06
Earliest Filing
2026-03-13
Latest Filing
partner: 2
investor: 1
target: 1
Counterparties (Filed by EQ)
4 relationshipsCompanies named in EQ's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| RA Capital Healthcare Fund, L.P. | — | investor | Private placement investor purchasing common stock and pre-funded warrants | 2026-03-13 | View |
| Jefferies LLC | JEF | partner | Sales agent and principal for open market sale of common stock | 2023-10-05 | View |
| Ono Pharmaceutical Co., Ltd. | — | partner | Equillium granted Ono an exclusive option to acquire rights to itolizumab in exchange for an upfront payment and funding | 2022-12-06 | View |
| Metacrine, Inc. | — | target | Target company in the merger agreement with Equillium, Inc. | 2022-09-06 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-26 | Unregistered Equity Sales; Regulation FD; Other Events; Exhibits | View | |
| 2026-10-05 | Other Events | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-05-29 | Shareholder Vote; Exhibits | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-03-25 | Earnings Release; Exhibits | View | |
| 2026-03-13 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-24 | Changes in Registrant's Certifying Accountant | View | |
| 2025-10-06 | Changes in Registrant's Certifying Accountant; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-09-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-04 | Other Events | View | |
| 2025-08-11 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-08-04 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Regulation | Agreement | View |
| 2025-06-13 | Notice of Delisting or Transfer | View | |
| 2025-05-22 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-04-24 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-06 | Other Events | View | |
| 2024-12-13 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR